| Date Filed | Type | Description |
| 06/07/2023 |
4
| COUGHLIN TIMOTHY (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 05/19/2023 |
4
| COUGHLIN TIMOTHY (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Gifted 6,000 shares
@ $0
Gifted 6,000 shares
@ $0
Granted 12,000 options to buy
@ $2.52, valued at
$30.2k
|
|
| 05/19/2023 |
4
| COUGHLIN TIMOTHY (Director) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Granted 4,500 shares
@ $0
Granted 13,500 options to buy
@ $17.11, valued at
$231k
|
|
| 04/28/2023 |
4
| COUGHLIN TIMOTHY (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Exercised 6,000 restricted stock units
@ $0 |
|
| 06/13/2022 |
4
| COUGHLIN TIMOTHY (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 8,650 shares
@ $0
Granted 11,893 options to buy
@ $23.48, valued at
$279.2k
|
|
| 06/06/2022 |
4
| COUGHLIN TIMOTHY (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 1,439 shares
@ $22.81, valued at
$32.8k
|
|
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2022 |
4
| COUGHLIN TIMOTHY (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 6,000 restricted stock units
@ $0 |
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| COUGHLIN TIMOTHY (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 1,428 options to buy
@ $4.21, valued at
$6k
|
|
| 05/19/2020 |
4
| COUGHLIN TIMOTHY (Director) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 9,000 options to buy
@ $15.43, valued at
$138.9k
|
|
| 05/08/2020 |
4
| COUGHLIN TIMOTHY (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 1,428 options to buy
@ $3.65, valued at
$5.2k
|
|
| 05/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2019 |
4
| Coughlin Timothy P (Director) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 2,000 shares
@ $0
Granted 8,000 options to buy
@ $17.94, valued at
$143.5k
|
|
| 05/10/2019 |
4
| Coughlin Timothy P (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 20,000 options to buy
@ $0.5834, valued at
$11.7k
|
|
| 05/07/2019 |
4
| Coughlin Timothy P (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 16,000 options to buy
@ $17.15, valued at
$274.4k
|
|
| 05/17/2018 |
4
| Coughlin Timothy P (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 20,000 options to buy
@ $1.35, valued at
$27k
|
|
| 05/11/2018 |
4
| Coughlin Timothy P (Director) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 2,500 shares
@ $0
Granted 10,000 options to buy
@ $26.52, valued at
$265.2k
|
|
| 05/04/2018 |
4
| Coughlin Timothy P (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 16,000 options to buy
@ $9.78, valued at
$156.5k
|
|
| 05/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/11/2017 |
4
| Coughlin Timothy P (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 20,000 options to buy
@ $3.15, valued at
$63k
|
|
| 05/04/2017 |
4
| Coughlin Timothy P (Director) has filed a Form 4 on FATE THERAPEUTICS INC |
| 04/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/10/2017 |
3
| Coughlin Timothy P (Director) has filed a Form 3 on aTYR PHARMA INC |
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/28/2016 |
4
| Coughlin Timothy P (Director) has filed a Form 4 on FATE THERAPEUTICS INC |
| 05/19/2016 |
4
| Coughlin Timothy P (Director) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 2,000 shares
@ $0
Granted 8,000 options to buy
@ $16.33, valued at
$130.6k
|
|
| 05/13/2016 |
4
| Coughlin Timothy P (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 25,000 options to buy
@ $1.69, valued at
$42.3k
|
|
| 02/09/2016 |
4
| Coughlin Timothy P (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 10,200 restricted stock units
@ $0
Granted 48,500 options
@ $35.99, valued at
$1.7M
Granted 20,500 restricted stock units
@ $0 |
|
| 02/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|